Trypanosoma cruzi relies on highly galactosylated molecules as virulence factors and the enzymes involved in sugar biosynthesis are potential therapeutic targets. The synthesis of UDP-galactose in T. cruzi requires the activity of phosphoglucomutase (PGM), the enzyme that catalyzes the interconversion of glucose-6-phosphate and glucose-1-phosphate. Several enzymes that participate in carbohydrate metabolism in trypanosomes are confined to specialized peroxisome-like organelles called glycosomes. The majority of glycosomal proteins contain peroxisome-targeting signals (PTS) at the COOH-or at the amino-terminus, which drive their transport to glycosomes. We had previously identified the T. cruzi PGM gene (TcPGM) and demonstrated that it encodes a functional enzyme. Here, we show that, in contrast to yeast and mammalian cells, TcPGM resides in glycosomes of the parasite. However, no classical PTS1 or PTS2 motif is present in its sequence. We investigated glycosomal targeting by generating T. cruzi cell lines expressing different domains of TcPGM fused to the green fluorescent protein (GFP). The analysis of the subcellular localization of fusion proteins revealed that an internal targeting signal of TcPGM, residing between amino acid residues 260 and 380, is capable of targeting GFP to glycosomes. These results demonstrate that, in T. cruzi, PGM import into glycosomes is mediated by a novel non-PTS domain that is located internally in the protein.
Introduction
Chagas disease, caused by the parasite Trypanosoma cruzi, affects millions of people in Central and South America. Thirty percent of infected individuals develop severe chronic inflammation of the heart and/or the smooth muscle of the digestive system, leading to a severe debilitating state (Dias 2006) . The surface of T. cruzi is covered by a dense coat of mucin-like molecules (T. cruzi sialoglycoproteins) (Previato et al. 1994 (Previato et al. , 1995 Mendonça-Previato et al. 2008 ) and glycoinositolphos-pholipids (Previato et al. 1990 (Previato et al. , 2004 , which are highly galactosylated, and protect the parasite from the immune response of the host (Buscaglia et al. 2006 ). The requirement of T. cruzi glycoconjugates for the successful establishment of the infection in mammalian hosts makes the enzymes participating in sugar nucleotide biosynthesis attractive drug targets. Since T. cruzi is incapable of metabolizing galactose by the Leloir pathway (Barrett et al. 1998) , the formation of UDP-galactopyranose (UDP-Galp) by the parasite is strictly dependent on the epimerization of UDP-glucose (UDP-Glc). Indeed, attempts to generate T. cruzi cell lines deficient in UDP-glucose 4 -epimerase were unsuccessful, suggesting that the gene is essential (MacRae et al. 2006) . Furthermore, single allele knockouts displayed aberrant morphology, including shortened flagellum and increased incidence of spheromastigotes, suggesting an essential role for galactosylated molecules in this parasite (MacRae et al. 2006) .
Phosphoglucomutase (PGM) is the pivotal enzyme that catalyzes the reversible interconversion of glucose-6-phosphate (Glc6P) into glucose-1-phosphate (Glc1P), an intermediate required for the synthesis of UDP-Galp. Accordingly, the activity of PGM should be essential for the biosynthesis of UDP-Galp in T. cruzi. In most organisms, the synthesis of sugar nucleotides occurs in the cytoplasm and the precursors are subsequently transported to the Golgi to be incorporated in sugar moieties (Hirschberg et al. 1998; Berninsome and Hirscherg 2000) . However, in T. brucei, UDP-glucose 4 -epimerase was found inside peroxisome-like organelles called glycosomes, suggesting a complex compartmentalization of sugar nucleotide biosynthesis in this organism (Roper et al. 2005) . It is not clear how the products would subsequently gain access to the cytoplasm or to the secretory pathway, where they serve as building blocks in the assembly of glycoconjugates.
Glycosomes are microbodies that share peroxisome functions such as β-oxidation of fatty acids and biosynthesis of ether lipids (Opperdoes and Borst 1977; Opperdoes 1987) . In addition, glycosomes present the unique compartmentalization of enzymes participating in glycolysis, the pentose phosphate pathway, purine salvage, and pyrimidine metabolism (Colasante et al. 2006) . One of the hallmarks of this organelle is the presence of the first seven enzymes of the glycolytic pathway . Since there is an apparent lack of activity regulation of certain glycolytic enzymes in trypanosomes by their products, it was proposed that this pathway must be compartmentalized in order to prevent the toxic accumulation of hexose-phosphates (Bakker et al. 2000) . Indeed, glycosomes are essential for the survival of the bloodstream form of T. brucei because prevention of the transport of glycolytic enzymes to glycosomes resulted in lethality (Furuya et al. 2002) . Recently, it was suggested that glycosomes are also important for the survival of Leishmania inside macrophages (McConville et al. 2007 ), reinforcing
Targeting of Trypanosoma cruzi PGM to glycosomes that molecules governing glycosome assembly and/or protein import to this organelle are attractive targets for chemotherapy.
The transport of glycosomal enzymes to the interior of the organelle generally occurs by association with carrier proteins called peroxins (PEX), which also mediate import to peroxisomes, through two classical targeting motifs. The majority of matrix proteins have the PTS1 motif at their extreme carboxyl terminus, consisting of the three amino acids SKL-or a conservative variant thereof (Gould et al. 1989; Neuberger et al. 2003 Petriv et al. 2004) . Few proteins lack both PTS1 and PTS2 but are nevertheless targeted to the peroxisomes; several of these proteins appear to be routed to the organelles by a polypeptide-internal sequence (I-PTS) (Moyersoen et al. 2004) .
Until very recently, glycosomes were viewed as organelles with an almost exclusive glycolytic role, at least so in T. brucei. Nevertheless, the growing identification of enzymes involved in sugar nucleotide biosynthesis in glycosomes brings the emerging view that pathways of sugar biosynthesis might also be sequestered in glycosomes (Roper et al. 2005; Stokes et al. 2008) . It is striking that the majority of such enzymes lack glycosome-targeting motifs, and the molecular mechanisms leading to their import into this organelle remain unknown. The location of enzymes involved in sugar nucleotide metabolism in T. cruzi is unknown. We have previously cloned the T. cruzi PGM gene (TcPGM) and demonstrated that it encodes a functional enzyme through complementation assays of Saccharomyces cerevisiae pgm1/ pgm2 (Penha et al. 2005) . Here, we show that PGM is located in glycosomes in T. cruzi, despite the lack of conventional PTS-targeting motifs supporting the notion that sugar nucleotide biosynthesis takes place in this organelle. Furthermore, we identified a new internal domain of the protein responsible for its sorting to T. cruzi glycosomes.
Results

Expression of phosphoglucomutase (TcPGM) in T. cruzi
The PGM gene of T. cruzi Dm28c (TcPGM) (AY695273), which was shown to encode a functional enzyme (Penha et al. 2005) , was fused to a 6× histidine tag for the production of recombinant TcPGM in Escherichia coli. The recombinant fusion protein was obtained as inclusion bodies, affinity-purified under denaturating conditions and subsequently used for the production of specific anti-serum. The anti-PGM antibody recognized a single 66 kDa protein in lysates of epimastigotes, which co-migrated with recombinant His-tagged TcPGM ( Figure 1A ). The antibody cross-reacted with a similar-sized protein in lysates of Leishmania major promastigotes (not shown), suggesting a high degree of conservation between T. cruzi and L. major PGM. We had previously detected mRNA for TcPGM in both the insectstage T. cruzi form, epimastigotes, and in infective trypomastigotes (Penha et al. 2005) . We verified the expression of PGM at the different life stages of T. cruzi by Western blot ( Figure 1B) . A single band of identical molecular mass was detected in the three stages and was more intense in epimastigotes, while the control of protein loading using an anti-BiP antibody was similar between the samples. Densitometry analyses to determine PGM levels normalized in relation to the levels of BiP revealed approximately 6-fold-higher expression of PGM in epimastigotes, as compared to the other two T. cruzi life stages.
Subcellular localization of TcPGM in T. cruzi
Next, we used affinity-purified antibodies to TcPGM to determine the subcellular localization of the enzyme by immunofluorescence ( Figure 2 ). We observed a complex pattern of staining in the three T. cruzi forms analyzed including diffuse cytosolic staining as well as punctate vesicular distribution throughout the cell body, suggestive of dual location in the cell. PGM is strictly cytoplasmic in mammalian cells and its substrates Glc6P and Glc1P are also found in the cytoplasm (Neufeld and Ginsburg 1965) . In trypanosomes however, the generation of Glc6P is thought to occur in glycosomes by hexokinase, which was found in the glycosome of T. brucei (Colasante et al. 2006) . To verify if PGM is associated with glycosomes, we performed double staining with antibodies to the glycosomal enzyme GAPDH (Misset et al. 1987) . The labeling with anti-TcPGM was intense throughout the parasite body and overlapped with that of anti-GAPDH in vesicular structures (Figure 2 , right panels), showing that TcPGM is associated with glycosomes in different forms of T. cruzi. Immunoelectron microscopy revealed that GAPDH positive vesicles ( Figure 3A and B, arrowheads) were also positive for TcPGM in their interior ( Figure 3B, arrows) , confirming the presence of TcPGM inside glycosomes. While GAPDH was found only inside the glycosome, TcPGM was L L Penha et al. also found in the surrounding cytoplasm or closely associated with the glycosomal membrane ( Figure 3C , white arrows).
The glycosomal distribution of TcPGM was further addressed by subcellular fractionation in sucrose gradients followed by Western blot analyses of the recovered fractions ( Figure 4 ). We detected TcPGM and GAPDH in the two higher density fractions (Figure 4 B3 and B4) and in the pellet (Figure 4 P), confirming that both proteins have a similar intracellular distribution. Previous work in T. cruzi reporting the fractionation procedure used here showed that the activity of hexokinase is highly increased in the higher density fractions (Vieira et al. 2005) , suggesting that the B3 and B4 higher density fractions where GADPH and PGM were detected correspond to glycosomeenriched fractions. Partition of membrane and soluble fractions of epimastigotes using Triton X-114 revealed that PGM was found mostly in the aqueous phase ( Figure 4B ), suggesting that TcPGM is mainly soluble in the parasite, arguing against a glycosome-membrane associated distribution.
Absence of classical peroxisomal-targeting motifs in phosphoglucomutase (PGM) and phosphomannomutase (PMM) of trypanosomatids
Classical PTS-type-targeting motifs similar to those identified in plants, mammals, and yeasts are absent from TcPGM. A study of in silico predictions of putative glycosomal enzymes of L. major and trypanosomes was reported, taking into account acceptable degeneracy in classical PTS-1-type motif (Opperdoes and Szikora 2006). The genomes of T. brucei, T. cruzi, and L. major were searched for sequences bearing PTS-targeting motifs at the C-or at the N-terminus, leading to the identification of 259 proteins containing putative glycosomal-targeting motifs. Among those, a gene present in both L. major (LmjF34.3780) and T. cruzi (Tc00.1047053508257.70) was identified as a putative phosphoglucomutase/phosphomannomutase-like protein (PGM/PMM). The predicted protein sequence of this gene revealed a PTS1-type motif, SKL in the L. major gene and SNL in the T. cruzi gene, at the C-terminus, and it was proposed that PGM is glycosomal in these organisms. However, the PGM/PMM gene described in the abovementioned study shows negligible similarity to TcPGM (AY695273) which we have shown to encode functional PGM (Penha et al. 2005) . Sequences sharing a high degree of similarity with TcPGM are present in L. major (CAC14526) and in L. infantum (LinJ21_V3.0700), but are absent from the T. brucei genome. A functional PMM was reported in L. mexicana (AJ308232) (Garami et al. 2001; Kedzierski et al. 2006 ), and we found sequences in L. major (LmjF36.1960 ) and in T. cruzi (Tc00.1047053510187.480), sharing 94% and 66% similarity with L. mexicana PMM, respectively, suggesting that those genes encode PMM in these organisms. Although in E. coli both the interconversions between Glc6P and Glc1P and between mannose-6-phosphate (Mn6P) and mannose-1-phosphate (Mn1P) are catalyzed by a single enzyme (PGM/PMM) with dual specificity (Shackelford et al. 2004) , the existence of such activity in trypanosomes has not been described. Based on these results, we propose that Leishmania and T. cruzi have two distinct genes encoding PGM and PMM enzymes that are different from the PGM/PMM-like gene containing a PTS-1 motif identified in silico (Opperdoes and Szikora 2006) . Canonical PTS-type sequences are absent from the abovementioned PGM and PMM genes of Leishmania and T. cruzi, suggesting that TcPGM is imported to glycosomes by alternative domains.
Targeting the TcPGM to glycosomes
In T. brucei, a greater degree of degeneracy is acceptable at the C-terminus PTS-1, where protein variants bearing the relaxed [S/A/C]-X-[L/Y/M] motif at the C-terminus could be transported to glycosomes in trypanosomes (Blattner et al. 1992 ). This degeneracy was taken into account in the algorithms used in the prediction of the putative glycosomal enzymes in Leishmania and trypanosomes. We found that TcPGM lacks PTS-1 and PTS-2 sequences at the C-terminus and at the N-terminus, respectively, even when acceptable degeneracy is taken into account ( Figure 5A ). As shown in Figure 5A , the three-amino-acid residues present at the carboxy terminal of TcPGM, VIT, or the first nine aminoacid residues ( Figure 5A respectively, identified in peroxisomal proteins ( Figure 5A , gray bars) (Subramani et al. 2000) or in putative PTS motifs predicted in silico for T. cruzi, T. brucei, and L. major glycosomal proteins ( Figure 5A , clear bars) (Opperdoes and Szikora 2006) . However, we observed four distinct tri-peptides containing degenerated PTS1-type motifs: SSL, HHL, PNA, and SEL dispersed throughout PGM ( Figure 5B ). In addition, we found a sequence resembling a PTS-2 motif
, located between residues 41 and 49 from the N-terminal end of TcPGM ( Figure 5B ). Although residues R and V (41-42) and Q (45 and 46) are compatible with a putative PTS-2, we did not observe the required five-residue spacing between V and Q.
In order to investigate if internal domains of PGM could mediate its targeting to glycosomes, we generated a series of constructs containing fusions of the green fluorescent protein (GFP) with truncated PGM gene fragments ( Figure 5B ). Each fragment was truncated at the region immediately subsequent to the putative degenerate tri-peptide internal PTS-motifs ( Figure 5 ). Since each truncation would leave an internal PTS-1 at the C-terminal extremity of the truncated protein, we fused the GFP gene at the 3 end of the TcPGM truncations, in order to keep the PTS-1 motif located internally in the fusion proteins, mimicking what is found in full-length TcPGM ( Figure 5B ).
The constructs were transfected into epimastigotes and stable geneticin-resistant cell lines were selected. The expression levels of GFP-tagged proteins in the different lines were assessed with antibodies to GFP and to TcPGM (Figure 6 ), revealing that the transfectants expressed the fusion proteins at similar levels. The level of fusion GFP-tagged proteins was comparable to that of endogenous PGM, minimizing the risk of excessive exogenous proteins saturating the glycosome transport machinery. Fluorescence microscopy analyses revealed that in parasites expressing GFP alone ( Figure 7A ) or the PGM-GFP fusions containing the first 60 (PGM60-GFP) residues ( Figure 7B ) or the first 260 (PGM260-GFP)-amino-acid residues of TcPGM ( Figure 7C ), the proteins were distributed throughout the cytoplasm. Co-labeling of these cells with antibodies to aldolase revealed a punctate distribution, typical of glycosomes, confirming that those tagged proteins were not transported into glycosomes in T. cruzi. In contrast, we observed a punctate vesicular distribution of fusion proteins TcPGM, L L Penha et al. Fig. 8 . Co-localization of PGM260-380-GFP fusion protein and aldolase in T. cruzi. Epimastigote lines tranfected with the construct containing residues 260-380 of TcPGM fused to GFP were fixed with 4% paraformaldehyde, adhered to poly-L-lysine, permeabilized with 1% NP-40 in PBS and incubated with anti-aldolase antibodies, followed by anti-rabbit IgG Alexa 546. Scale bar 4 μm.
lacking the C-terminal 40-amino-acid residues (PGM560-GFP) ( Figure 7E ), lacking the C-terminal 220-amino-acid residues (PGM380-GFP) ( Figure 7D ) or with full-length PGM-GFP ( Figure 7F ). The GFP containing vesicles were positive for aldolase in all cases, indicating that those fusion proteins were efficiently imported to glycosomes. These results show that the domain located between residues 260 and 380 of TcPGM is capable of mediating the transport of GFP to T. cruzi glycosomes. We further addressed this hypothesis by constructing a fusion of residues 260-380 of TcPGM and GFP (Figure 8 ). In order to maintain GFP fused at the C-terminus, we introduced a start codon immediately before residue 260. The analysis of the T. cruzi lines selected after transfection with this construct revealed a vesicular distribution of GFP, which fully co-localized with aldolase, confirming that the 100-residue internal domain of TcPGM is sufficient to drive the transport of foreign proteins into T. cruzi glycosomes (Figure 8 ).
Discussion
We had previously reported the activity of T. cruzi PGM in a heterologous expression system, showing that the TcPGM gene we identified encodes a functional enzyme (Penha et al. 2005) . Here, we extended the characterization of TcPGM and show that it is expressed in the three life stages of the parasite, at higher levels in epimastigotes. Epimastigotes have a larger cell surface area in comparison with trypomastigotes and amastigotes, which combined to a fast growing rate, might require intensified sugar nucleotide biosynthesis in order to attend the demand of glycoconjugate turnover in rapidly dividing epimastigotes. Along these lines, the interconversion between Glc6P and Glc1P by PGM provides adequate amounts of precursors for the synthesis of UDP-Glc, which would then be used to generate UDP-Galp, UDP-Galf, UDP-Rha, and UDP-Xyl. Indeed, a recent study of the sugar nucleotide pools of different trypanosomatids revealed that T. cruzi epimastigotes have the highest pool size of UDPGlc and also, at least a 2-fold larger pool of UDP-GlcNAc, in comparison with T. brucei and L. major insect forms , supporting the idea of higher rates of sugar nucleotide biosynthesis in this life form.
Our immunofluorescence and immunocytochemistry analyses, combined with subcellular fractionation, showed that TcPGM is located in glycosomes. This was unexpected because in other organisms, the interconversion between Glc6P and Glc1P occurs in the cytoplasm. Furthermore, the amino acid sequence of TcPGM does not contain any obvious glycosomaltargeting signals. Recently, it was reported that GDP-mannose dehydratase (GMD) is located in glycosomes in T. brucei, despite the lack of PTS-type sequences ). Other enzymes involved in sugar nucleotide biosynthesis were also found in glycosomes in T. brucei, but the biological significance of these findings remains unclear (Roper et al. 2005; Stokes et al. 2008) . It was recently shown that pathway compartmentalization, at least so of glycolytic enzymes, is an essential alternative to allosteric regulation in T. brucei and protects the parasite from the accumulation of toxic metabolites (Haanstra et al. 2008) . Since the synthesis of GDP-Man occurs in the cytoplasm in most organisms, it was suggested that the sequestration of GMD in glycosomes could provide a way of metabolically controlling the rate of GDP-Fuc biosynthesis . Alternatively, the compartmentalization of enzymes involved in sugar nucleotide biosynthesis could optimize the output of product in situations where enzyme amounts are the limiting steps of the reaction. In agreement with this idea, it was shown that T. cruzi epimastigote cell lines that are single allele knock-outs for UDP-glucose 4 -epimerase have deficiency with respect to galactose metabolism, suggesting that epimerase levels are close to limiting in epimastigotes (MacRae et al. 2006) .
Despite the majority of TcPGM seemed to be concentrated in GAPDH positive organelles, we also observed significant labeling in the cell body, indicating that a pool of TcPGM is in the cytoplasm. At present, we cannot discriminate if there is a permanent cytoplasmic pool of TcPGM or if this represents recently synthesized protein that is on its way to glycosomes. In T. brucei procyclic forms, D-glucose is transported to glycosomes, where it is phosphorylated by hexokinase to generate Glc6P, the substrate for PGM (Bringaud et al. 2006 ). More recently, it was shown that Glc6P accumulates upon the glucose addition to PEX14-deficient trypanosomes, which are impaired in glycosomal protein import, providing strong evidence that pathways that utilize Glc6P are carried on by glycosomal enzymes (Haanstra et al. 2008) . We expect that these pathways are conserved in T. cruzi, consistent with the glycosomal localization of TcPGM.
The localization of a putative PGM/PMM-like protein containing a PTS-1 motif in glycosomes of L. major and T. cruzi was previously proposed by an in silico study (Opperdoes and Szikora 2006) . However, we found that the genes encoding such proteins in T. cruzi and L. major are substantially Targeting of Trypanosoma cruzi PGM to glycosomes different from the TcPGM gene and from the putative PGM gene of L. major. In addition, we found sequences sharing high similarity with the PMM gene of L. mexicana, which was proven to encode a functional enzyme (Garami et al. 2001 ). Although we cannot discard that a PGM/PMM-like protein exists in trypanosomatids, we propose that T. cruzi and Leishmania have two distinct genes encoding PGM and PMM, which lack classical glycosome-targeting motifs (PTS).
Peroxisomal protein import mechanisms are highly conserved throughout nature (Gould et al. 1990) and are shared by trypanosomatids for the import of proteins into glycosomes. Although classical PTS motifs can be found in trypanosomatid proteins, it has been long known that some degree of degeneracy is accepted (Blattner et al. 1992) . The most common targeting signal is PTS-1, a carboxylterminal tri-peptide recognized by its cytosolic receptor, Pex5p (Brown and Baker 2008) . We could not identify classical or degenerated PTS-1-type motifs at the C-terminus of TcPGM, either by computer analyses or by visual screening of the sequence. Intriguingly, visual scrutiny revealed six tri-peptide sequences compatible with degenerated PTS-1 motif distributed internally throughout TcPGM.
The use of truncated TcPGM-GFP fusions allowed the evaluation of such putative-targeting domains. The fusion protein truncated at residue 260 containing the putative PTS-1, SSL, could not be transported to glycosomes, while the fusion protein truncated at residue 380, which contained both putative PTS-1, SSL, and HHL, was located in glycosomes, suggesting that the region between residues 260 and 380 is essential for protein import to glycosomes. Furthermore, a fusion protein containing solely the residues comprised between positions 260 and 380 of TcPGM fused to GFP was efficiently transported to glycosomes, clearly showing that this domain of 120 residues is sufficient to drive the transport of GFP to glycosomes. We did not address if the HHL tri-peptide is responsible for the targeting or if some other sequence or conformational constraint is required for sorting to glycosomes. In any case, the domain responsible for glycosome targeting is not located at the C-terminus or at the N-terminus of the fusion protein, and thus, is not available for direct binding to the transport receptors Pex5 or Pex7. This demonstrates that in T. cruzi, TcPGM import into glycosomes is mediated by a novel non-PTS domain that is located internally. Interestingly, we observed that fusion proteins containing the TcPGM sequence spanning from residues 1 to 380 seem exclusively located in glycosomes, while the fusion proteins spanning domains further down or the full-length construct are located both in glycosomes and in the cytoplasm. An attractive possibility is that additional domains of TcPGM located between residues 380 and 600 are involved in the temporary retention of the protein in the cytoplasm.
Although the majority of protein import into peroxisomes and glycosomes relies on the interaction between C-terminal domains and Pex5, there are reports of proteins lacking both PTS-1 and PTS-2 which are transported to peroxisomes through alternative mechanisms (Brown and Baker 2008) . In most cases, such proteins travel to glycosomes via a Pex5p-dependent mechanism, which is believed to occur via interaction with other proteins containing classical PTS, designated as "piggy-back" import. In addition, it has been reported that acyl CoA oxidase (AOX) from S. cerevisiae, which lacks specific PTS signals, interacts with Pex5p via novel contact sites (Klein et al. 2002) . The interaction region in Pex5 lies outside of the domain involved in PTS-1 recognition, while the interaction site in AOX is located internally (Klein et al. 2002) . This novel site was proposed as PTS-3 or I-PTS (internal PTS). Currently, it is accepted that I-PTS proteins, at least to some extent, form oligomeric complexes with PTS1 or PTS2 containing proteins, being transported as multimeric molecules also by "piggy backing." In yeast, it has been shown that PGM can make interactions with different proteins, being found in the calmodulin protein complex (Takahashi et al. 2004 ) and supporting the notion that PGM can form complexes with other proteins in the cytoplasm. An alternative is that TcPGM is transported to glycosomes through "piggy backing," by the interaction with other PTS containing proteins.
Material and methods
Parasite culture T. cruzi epimastigotes (Dm28c) were cultivated at 28 • C in the liver infusion tryptose medium (LIT) containing 10% fetal calf serum (FCS, Cultilab, Rio de Janeiro, Brazil). Tissue culture trypomastigotes (TCTs) were harvested from the supernatants of infected LLMCK cell cultures maintained in Dulbecco's Modified Eagle's medium (DMEM, Sigma, St. Louis, MO) supplemented with 2% FCS in a 5% CO 2 humidified atmosphere, at 37
• C. For the obtention of amastigotes, LLMCK cultures were infected at high rates with TCT and after 3 days, the cultures were incubated with DMEM supplemented with 200 mg/L sodium bicarbonate, at 37
• C in the absence of CO 2 overnight. The following day, amastigotes released to the medium as a result of cell disruption were harvested by centrifugation.
Construction of GFP-TcPGM expression plasmid
The coding region of the GFP gene was amplified from the pEGFP vector (Invitrogen) by PCR using Phusion DNA polymerase with a forward oligonucleotide primer containing an EcoRI site and a reverse oligonucleotide primer harboring a SalI site. After digestion with EcoRI and SalI (New England Biolabs, Ipswich, MA), the PCR product was cloned in the pTEX expression vector (Kelly et al. 1992) . Different domains of TcPGM were fused to the N-terminus of GFP by amplifying the TcPGM gene by PCR, using Phusion DNA (Finnzymes, Finland) polymerase and the appropriate sets of primers (Table I). For the constructs of full-length PGM-GFP (TcPGM-GFP) and PGM with truncations at residues 60 (PGM60-GFP), 260 (PGM260-GFP), 380 (PGM380-GFP), and 560 (PGM560-GFP), the forward primer PGMF (SmaI site) was used in combination with different reverse primers (CTR I-IV) that have EcoRI sites to clone in fusion with GFP (Table I) . For the construction of a fusion containing residues 260-380 of TcPGM and GFP (PGM260-380-GFP), a primer was designed corresponding to part of the 5 -flanking region of TcPGM containing: (i) a transsplicing acceptor site (bold); (ii) a 18 nucleotide spacer region; and (iii) the start codon (underline), followed by residue 260 of the coding region of TcPGM (CTF2). This primer was used to amplify the desired fragment using the open reading frame of TcPGM as a template and CTR3 reverse primer. The EcoRISmaI fragments of the PCR products were each inserted into the EcoRI-SmaI pTEX vector. The resulting plasmids (pTEX-PGMX-GFP) were confirmed by DNA sequencing before transfection. 
Parasite transfection
Log-phase epimastigotes (5 × 10 8 ) were washed twice in PBS (20 mM phosphate buffer, 150 mM NaCl, pH 7.2) and resuspended in 25 mM HEPES, 140 mM NaCl and 0.4 mM Na 2 HPO 4 (pH 7.0). The cells were transferred to a 0.2 cm electroporation cuvette, incubated with 30 μg purified plasmid (empty vector, pTEX-GFP or pTEX-PGM-GFP constructs) on ice for 5 min and subsequently electroporated with one pulse at 500 μF, 450 kV. The cells were cultivated overnight in the LIT medium containing 10% FCS and subsequently selected for 4 weeks with 200 μg mL −1 geneticin (G418, Life Technologies). The transfected cell populations were maintained in culture for additional 4 weeks before analysis. The expression of the PGM-GFP fusion proteins was verified by Western blot using an anti-GFP or anti-TcPGM antibody.
Antibodies and Western blotting
Approximately 100 μg purified recombinant PGM was mixed at 1:1 with complete Freund's adjuvant and inoculated intraperitoneally in mice. After 21 days, the animals received three consecutive boosts at 2-week intervals with additional 100 μg each of the antigen, until an adequate response was achieved. The sera obtained from 10 mice were pooled. Western blots for PGM were performed using 50 μg of parasite lysates or 5 μg of recombinant TcPGM. T. cruzi lysates were obtained by repeated cycles of freeze and thaw followed by the addition of 1% Triton X-100; after 10 min on ice, the samples were cleared by centrifugation at 13,000 × g and the protein concentration was determined using the Dc-Bioassay kit (Bio-Rad). Samples were mixed with the SDS-PAGE sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol (βME), 0.012% bromophenol blue) and subsequently boiled for 3 min before application to 11% SDS-PAGE. Electrophoresed proteins were transferred to nitrocellulose membranes and blocked with 9% non-fat milk in TBS, 0.05% Tween-20. Antiserum to recombinant PGM (1:1000) was incubated for 1 h and secondary alkaline-phosphatase-conjugated anti-mouse IgG antibody (1:2000) was used for detection. The reactive bands were visualized using the BCIP-NBT solution provided by the manufacturer. Anti-GFP antibodies (Invitrogen) were used at a 1:4000 dilution. Antibodies against the endoplasmic reticulumresident hsp70 gene family member (anti-BIP) of T. brucei, provided by Professor J. Bangs from the University of Wisconsin School of Medicine and Public Health, Wisconsin, USA, which cross-react with T. cruzi BiP, were used as a loading control for Western blots, at 1:2000. Rabbit antiserum to T. brucei glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or antiserum to T. brucei aldolase (ALD) was provided by Professor F. Opperdoes, Université Catholique de Louvain, Brussels, and were used at 1:2000.
Cell fractionation
Reservosomes fraction was obtained according to Cunha-eSilva et al. (2002) . Briefly, epimastigotes were harvested by centrifugation, washed twice in the TMS buffer (20 mM TrisHCl, pH 7.2, containing 2 mM MgCl 2 and 250 mM sucrose) and resuspended in 13 mL of the same buffer. Parasites were carefully disrupted on ice with 15 cycles of 2 s, with 1 s rest between cycles, in an ultrasonic apparatus (Sigma, GEX 600 Model) using a standard probe (13 mm radiating diameter), operating at 10% of total amplitude, yielding a total homogenate. After centrifugation at 2450 × g for 10 min, the pellet was discarded and the supernatant mixed with an equal volume of 2.3 M sucrose. Twelve milliliters of the mixture was deposited in a Beckman SW28 centrifuge tube, overlaid with 10 mL of 1.2 M, 10 mL of 1.0 M and 5 mL of 0.8 M sucrose and centrifuged at 97,000 × g for 150 min. All sucrose solutions were prepared in the TM buffer (20 mM Tris-HCl, pH 7.2, containing 2 mM MgCl2). All the interfaces (B1, B2, and B3, from top to bottom), the bottom layer (B4, 1.27 M final sucrose concentration) and the pellet (P) were collected, diluted in the TMS buffer and centrifuged at 120,000 × g for 30 min at 4
• C. Subsequently, the pellets were resuspended in TMS supplemented with protease inhibitor cocktail (Sigma P2714) and processed for Western blot. An aliquot of each sample was fixed with 2.5% glutaraldehyde in TMS, post-fixed with 1% osmium tetroxide in 0.1 M cacodylate buffer, pH 7.2, dehydrated in acetone series and embedded in Epon. Ultrathin sections were extensively examined under a JEOL 1200X electron microscope to control subcellular fractionation.
Partition of T. cruzi soluble and membrane-associated fractions
Epimastigotes of T. cruzi were washed in PBS and resuspended in 0.1 M Tris-HCl, 0.15 M NaCl, pH 7.4, 2% Triton X-114 (Sigma), containing protease inhibitors. The extract was prepared on ice for 30 min, subsequently warmed at 37
• C for 10 min, and then centrifuged at 12,000 × g for 10 min at room temperature to effect phase separation. Each phase was re-extracted twice and the samples of the detergent and aqueous phases were collected separately. They were further processed identically, but separately. Each phase was loaded onto an 11% SDS-PAGE polyacrylamide gel, transferred to nitrocellulose, blocked with 9% non-fat milk in PBS, 0.05% Tween-20, and
